Physical Therapy Versus Watchful Waiting for the Treatment of Adhesive Capsulitis of the Shoulder: A Prospective Randomized Controlled Trial

Author(s)

Martin SD1, Dean M1, Cherian NJ1, Eberlin C2, Kucharik MP3, Abraham PF4, Nazal MR5, Conaway WK6
1Massachusetts General Hospital, Boston, MA, USA, 2Massachusetts General Hospital, PEORIA, IL, USA, 3University of South Florida, Tampa, FL, USA, 4University of Southern California, Los Angeles, CA, USA, 5University of Kentucky, Lexington, KY, USA, 6Thomas Jefferson University, Philadelphia, PA, USA

Presentation Documents

OBJECTIVES: To integrate patient-reported outcome measures (PROMs) and health care costs to compare the value achieved by watchful waiting (WW) versus physical therapy (PT) for the conservative management of adhesive capsulitis (frozen shoulder).

METHODS: Patients in this prospective, parallel randomized controlled trial who were diagnosed with adhesive capsulitis of the shoulder were randomized 1:1 to WW or PT. The primary outcome was the American Shoulder and Elbow Surgeons Score (ASES), and secondary outcomes included patient value (defined here as the 12-month ASES score divided by health care costs), the Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire, and Visual Analog Scale (VAS) pain scores. Outcomes were assessed at baseline and at 6 weeks, 3 months, 6 months, and 12 months. Primary analyses were conducted following intention-to-treat principles using linear mixed-effects models. Sensitivity analyses incorporated nonlinear mixed-effects models and as-treated analyses.

RESULTS: Between November 2014 and November 2022, we screened 175 patients, 61 of whom (34.9%) were assigned WW (31 patients, 51.8%) or PT (30 patients, 49.2%). Relative to baseline scores, patients from both cohorts improved significantly at each time point and for all PROMs (p < 0.05 for all). However, there were no significant differences in PROMs between treatment modalities at any time point (p > 0.05 for all). Compared to those assigned WW, patients randomized to PT incurred 9.98x higher costs (normalized mean difference: 1,635.67, 95% confidence interval: 967.19 to 2,304.15; p < 0.001) and achieved only 16.9% of the patient value (normalized mean difference: -146.97, 95% confidence interval: -207.47 to -86.47; p < 0.001). These results held across a range of sensitivity analyses.

CONCLUSIONS: In this study, patients randomized to PT reported similar PROMs but significantly higher costs than those undergoing WW, demonstrating WW as the higher value treatment modality for the conservative management of adhesive capsulitis.

Conference/Value in Health Info

2023-05, ISPOR 2023, Boston, MA, USA

Value in Health, Volume 26, Issue 6, S2 (June 2023)

Code

CO107

Topic

Clinical Outcomes

Topic Subcategory

Clinical Outcomes Assessment, Comparative Effectiveness or Efficacy

Disease

No Additional Disease & Conditions/Specialized Treatment Areas

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×